Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019)
Pulmonary Circulation · 2024-04 · 14 (2)
DOI: 10.1002/pul2.12374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pulmonary Circulation, online erschienen am 09.05.2024. Verfasst von Adam S Vohra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology Weill Cornell Medical College New York New York USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a sequela of a pulmonary embolus that occurs in approximately 1%−3% of patients. Pulmonary thromboendoarterectomy (PTE) can be a curative procedure, but balloon pulmonary angioplasty (BPA) has emerged as an option for poor surgical candidates. We used the National Inpatient Sample to query patients who underwent PTE or BPA between 2012 and 2019 with CTEPH. The primary outcome was a composite of in‐hospital mortality, myocardial infarction, stroke, tracheostomy, and prolonged mechanical ventilation. Outcomes were compared between low‐ and high‐volume centers, defined as 5 and 10 procedures per year for BPA and PTE, respectively. During our study period, 870 BPA and 2395 PTE were performed. There was a 328% relative increase in the number of PTE performed during the study period. Adverse events for BPA were rare. There was an increase in the primary composite outcome for low‐volume centers compared to high‐volume centers for PTE (24.4% vs. 12.1%, p = 0.003). Patients with hospitalizations for PTE in low‐volume centers were more likely to have prolonged mechanical ventilation (20.0%% vs. 7.2%, p < 0.001) and tracheostomy (7.8% vs. 2.6%, p = 0.017). In summary, PTE rates have been rising over the past 10 years, while BPA rates have remained stable. While adverse outcomes are rare for BPA, patients with hospitalizations at low‐volume centers for PTE were more likely to have adverse outcomes. For patients undergoing treatment of CTEPH with BPA or PTE, referral to high‐volume centers with multidisciplinary teams should be encouraged for optimal outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology Weill Cornell Medical College New York New York USA.
- SUNY Upstate Medical School Syracuse New York USA.
- Department of Medicine, Division of Cardiology Columbia University Irving Medical Center New York New York USA.
- Department of Medicine, Division of Cardiology University of Washington Seattle Washington USA.
ORCID-Profile: Adam S Vohra
Zitieren
APA
Vohra, A. S., Olonoff, D. A., Ip, A., Kirtane, A. J., Steinberg, Z., Horn, E., Krishnan, U., Reisman, M., Bergman, G., Wong, S. C., Feldman, D. N., Kim, L. K., & Singh, H. S. (2024). Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019). Pulmonary Circulation, 14(2). https://doi.org/10.1002/pul2.12374
Vancouver
Vohra AS, Olonoff DA, Ip A, Kirtane AJ, Steinberg Z, Horn E, et al. Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019). Pulmonary Circulation. 2024;14(2). doi:10.1002/pul2.12374
BibTeX
@article{Vohra2024,
author = {Vohra, Adam S and Olonoff, Danielle A and Ip, Ada and Kirtane, Ajay J and Steinberg, Zachary and Horn, Evelyn and Krishnan, Udhay and Reisman, Mark and Bergman, Geoffrey and Wong, Shing-Chiu and Feldman, Dmitriy N and Kim, Luke K and Singh, Harsimran S},
title = {Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019)},
journal = {Pulmonary Circulation},
year = {2024},
volume = {14},
number = {2},
doi = {10.1002/pul2.12374}
}
EUVIMED